These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12147201)

  • 21. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
    Shin SS; Byun Y; Lim KM; Choi JK; Lee KW; Moh JH; Kim JK; Jeong YS; Kim JY; Choi YH; Koh HJ; Park YH; Oh YI; Noh MS; Chung S
    J Med Chem; 2004 Feb; 47(4):792-804. PubMed ID: 14761182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
    Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
    J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II.
    Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N
    Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
    Rao PN; Uddin MJ; Knaus EE
    J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds.
    Momin RA; De Witt DL; Nair MG
    Phytother Res; 2003 Sep; 17(8):976-9. PubMed ID: 13680840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
    Liu CY; Lai YY; Lo CJ
    J Surg Res; 2004 Apr; 117(2):223-31. PubMed ID: 15047127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
    Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
    Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
    Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
    Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro.
    Mohseni H; Zaslau S; McFadden D; Riggs DR; Jackson BJ; Kandzari S
    J Surg Res; 2004 Jun; 119(2):138-42. PubMed ID: 15145695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
    Alcaide P; Fresno M
    Eur J Immunol; 2004 Jun; 34(6):1695-704. PubMed ID: 15162440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAF is involved in the Mycoplasma arthritidis superantigen-triggering pathway for iNOS and COX-2 expression in murine peritoneal cells.
    Shio MT; Ribeiro-Dias F; Timenetsky J; Jancar S
    Exp Cell Res; 2004 Aug; 298(1):296-304. PubMed ID: 15242784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems.
    Giuliano F; Warner TD
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
    Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
    Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.